https://www.immunoinsights.co/resources/autoantibody-profiling-in-prostvac-and-ipilimumab-treated-prostate-cancer-patients-reveals-potential-biomarkers-of-immune-related-adverse-events/ 2026-10-19T18:49:06+00:00 https://www.immunoinsights.co/app/uploads/2026/10/publication-screeenshot.png https://www.immunoinsights.co/resources/blood-test-for-smokers-could-slash-death-rates-from-lung-cancer-by-detecting-the-disease-four-years-before-it-shows-up-on-scans/ 2026-10-19T18:50:45+00:00 https://www.immunoinsights.co/resources/ground-breaking-blood-test-could-reduce-lung-cancer-deaths/ 2026-10-19T18:51:32+00:00 https://www.immunoinsights.co/resources/new-blood-test-trialled-on-12000-scots-catches-lung-cancer-early/ 2026-10-19T18:52:20+00:00 https://www.immunoinsights.co/resources/oncimmune-submission-to-health-and-social-care-committee-inquiry/ 2026-10-19T18:52:59+00:00 https://www.immunoinsights.co/resources/simple-blood-test-that-could-spot-deadly-lung-cancer-is-saving-lives-by-detecting-disease-years-before-symptoms-show/ 2026-10-19T18:53:51+00:00 https://www.immunoinsights.co/resources/we-are-living-in-testing-times/ 2026-10-19T18:55:06+00:00 https://www.immunoinsights.co/resources/making-the-right-decisions-with-the-right-tools/ 2026-10-19T18:56:46+00:00 https://www.immunoinsights.co/resources/diagnostics-why-are-they-now-getting-the-attention-they-deserve/ 2026-10-19T18:57:50+00:00 https://www.immunoinsights.co/resources/professor-gino-martini-in-conversation-with-adam-m-hill-extra-time-podcast/ 2026-10-19T18:59:29+00:00 https://www.immunoinsights.co/resources/contract-signed-with-verily-life-sciences-an-alphabet-company-to-profile-autoantibodies-for-long-covid-19/ 2026-10-19T19:00:07+00:00 https://www.immunoinsights.co/app/uploads/2026/10/6-1.webp https://www.immunoinsights.co/resources/immunoinsights-and-synexa-life-sciences-sign-go-to-market-service-partnership/ 2026-10-19T19:00:52+00:00 https://www.immunoinsights.co/app/uploads/2026/10/5-1.webp https://www.immunoinsights.co/resources/immunoinsights-signs-contract-with-leading-top-10-global-pharmaceutical-company-to-profile-biomarkers-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp/ 2026-10-19T19:01:40+00:00 https://www.immunoinsights.co/app/uploads/2026/10/top-10-global-pharma.webp https://www.immunoinsights.co/resources/follow-on-contract-signed-with-leading-us-medical-research-organisation-to-validate-previous-profiling-in-covid-19/ 2026-10-19T19:02:15+00:00 https://www.immunoinsights.co/app/uploads/2026/10/medical-research-COVID-19.webp https://www.immunoinsights.co/resources/oncimmune-signs-contracts-with-us-based-clinical-stage-biopharmaceutical-companies-developing-immunotherapies-one-of-which-is-focused-on-car-nk-cell-therapies/ 2026-10-19T19:03:08+00:00 https://www.immunoinsights.co/app/uploads/2026/10/us-based-contract.webp https://www.immunoinsights.co/resources/oncimmune-receives-queens-award-for-enterprise-in-innovation-2022/ 2026-10-19T19:03:39+00:00 https://www.immunoinsights.co/app/uploads/2026/10/news-queen-awards.webp https://www.immunoinsights.co/resources/paradoxical-sex-specific-patterns-of-autoantibodies-response-to-sars-cov-2-infection/ 2026-10-19T19:05:23+00:00 https://www.immunoinsights.co/app/uploads/2026/10/JTM_Paradoxical-screenshot.webp https://www.immunoinsights.co/resources/has-this-doctor-revolutionised-lung-cancer-detection/ 2026-10-19T19:06:08+00:00 https://www.immunoinsights.co/app/uploads/2026/10/news-nov-post-1.webp https://www.immunoinsights.co/app/uploads/2026/10/news-nov-post-1.webp https://www.immunoinsights.co/resources/oncimmune-to-participate-at-the-asco-2023-meeting/ 2026-10-19T19:08:13+00:00 https://www.immunoinsights.co/app/uploads/2026/10/ASCOAM23LinkedIn.jpg https://www.immunoinsights.co/app/uploads/2026/10/ASCOAM23LinkedIn-1024x536.jpg https://www.immunoinsights.co/resources/oncimmune-provides-update-on-recent-trading-and-the-outlook-for-2024/ 2026-10-19T19:08:52+00:00 https://www.immunoinsights.co/app/uploads/2026/10/AR-News2-1.png https://www.immunoinsights.co/app/uploads/2026/10/AR-News2-300x200.png https://www.immunoinsights.co/resources/advancing-precision-medicine-insights-from-bio2024/ 2026-10-19T19:09:28+00:00 https://www.immunoinsights.co/app/uploads/2026/10/blog.png https://www.immunoinsights.co/resources/oncimmune-announces-six-month-interim-results/ 2026-10-19T19:10:16+00:00 https://www.immunoinsights.co/app/uploads/2026/10/Interim2.png https://www.immunoinsights.co/resources/2833-2/ 2026-10-19T19:11:08+00:00 https://www.immunoinsights.co/app/uploads/2026/10/News2.png https://www.immunoinsights.co/resources/us-1-5m-contract-win-with-top-10-pharma-company/ 2026-10-19T19:14:12+00:00 https://www.immunoinsights.co/app/uploads/2026/10/IgE-Press-Release.png https://www.immunoinsights.co/resources/additional-contract-win-with-top-10-pharma-company/ 2026-10-19T19:15:49+00:00 https://www.immunoinsights.co/app/uploads/2026/10/PRESS-22.png https://www.immunoinsights.co/resources/proust-on-discovery-why-alden-scientific-acquired-oncimmune-gmbh/ 2026-10-19T19:18:18+00:00 https://www.immunoinsights.co/app/uploads/2026/10/14-scaled-1.png https://www.immunoinsights.co/resources/alden-scientific-acquires-oncimmune-germany-gmbh-expanding-global-leadership-in-multi-omic-research-and-precision-medicine/ 2026-10-19T19:18:56+00:00 https://www.immunoinsights.co/app/uploads/2026/10/Alden-Scientific-Press-Release.png https://www.immunoinsights.co/resources/redefining-microbiome-pathology-through-autoantibody-biomarkers/ 2026-10-19T19:22:39+00:00 https://www.immunoinsights.co/app/uploads/2026/10/MICRO.jpg https://www.immunoinsights.co/resources/autoantibodies-in-neurology-pioneering-new-paths-in-disease-detection-and-treatment/ 2026-10-19T19:23:33+00:00 https://www.immunoinsights.co/app/uploads/2026/10/neuro-blog-updated-image-1.png https://www.immunoinsights.co/resources/extra-time-podcast-in-conversation-with-professor-frank-sullivan/ 2026-10-19T19:24:43+00:00 https://www.immunoinsights.co/resources/siemens-healthineers-and-oncimmune-partner-to-improve-malignancy-risk-assessment-of-indeterminate-pulmonary-nodules-ipns/ 2026-10-19T19:25:55+00:00 https://www.immunoinsights.co/app/uploads/2026/10/Siemens-Lung-Web-NEws-1200-%C3%97657-px.png https://www.immunoinsights.co/app/uploads/2026/10/Siemens-Lung-Web-NEws-1200-%C3%97657-px.png https://www.immunoinsights.co/resources/oncimmune-announces-strategy-updates-and-changes-to-the-board-of-directors/ 2026-10-19T19:26:36+00:00 https://www.immunoinsights.co/app/uploads/2026/10/Knowledge-Centre-News-1200-%C3%97-800-px-1.png https://www.immunoinsights.co/resources/martine-gouldstone-ceo-updates-investors-on-oncimmunes-new-strategy/ 2026-10-19T19:28:45+00:00 https://www.immunoinsights.co/resources/progress-against-strategy/ 2026-10-19T19:29:24+00:00 https://www.immunoinsights.co/app/uploads/2026/10/News.png https://www.immunoinsights.co/resources/dr-james-jett-in-conversation-with-adam-m-hill-extra-time-podcast/ 2026-10-19T19:30:11+00:00 https://www.immunoinsights.co/resources/oncimmune-targets-age-related-diseases-with-biomarker-research/ 2026-10-19T19:34:45+00:00 https://www.immunoinsights.co/app/uploads/2026/10/Ageing.png https://www.immunoinsights.co/resources/poster-cancer-immunotherapy-array-a-novel-screening-tool-for-immune-system-profiling-in-cancer-immunotherapy-bridging-autoimmunity-and-cancer/ 2026-10-19T19:36:35+00:00 https://www.immunoinsights.co/app/uploads/2026/10/poster-2-for-click-for-more-1.png https://www.immunoinsights.co/app/uploads/2026/10/Poster2-1-scaled-1.jpg https://www.immunoinsights.co/resources/1772-2/ 2026-10-19T19:37:26+00:00 https://www.immunoinsights.co/app/uploads/2026/10/Poster-1-for-click-for-more-1.png https://www.immunoinsights.co/app/uploads/2026/10/Poster-1-3-scaled-1.jpg https://www.immunoinsights.co/resources/poster-autoantibody-profiling-in-prostvac-and-ipilimumab-treated-prostate-cancer-patients-reveals-potential-biomarkers-of-immune-related-adverse-events/ 2026-10-19T19:38:16+00:00 https://www.immunoinsights.co/app/uploads/2026/10/poster3-for-click-for-more-1.png https://www.immunoinsights.co/app/uploads/2026/10/Poster3-1-scaled-1.jpg https://www.immunoinsights.co/resources/poster-multiplexed-autoantibody-profiling-of-patients-with-metastatic-urothelial-carcinoma-receiving-immune-checkpoint-inhibitors-or-platinum-based-chemotherapy-oncimmune-collaboration-asco-genito/ 2026-10-19T19:39:10+00:00 https://www.immunoinsights.co/app/uploads/2026/10/Posters-2022-click-for-more-1.webp https://www.immunoinsights.co/app/uploads/2026/10/Poster1-2022-1-scaled-1.jpg https://www.immunoinsights.co/resources/video-oncimmune-scientists-decode-autoantibody-reactome-using-xmap-technology/ 2026-10-19T19:39:48+00:00 https://www.immunoinsights.co/app/uploads/2026/10/video-lumn.png https://www.immunoinsights.co/app/uploads/2026/10/BLOG31466.InCopyImage.2-300x300.png https://www.immunoinsights.co/resources/comprehensive-multiplexed-autoantibody-profiling-of-patients-with-advanced-urothelial-cancer-2/ 2026-10-19T19:40:28+00:00 https://www.immunoinsights.co/app/uploads/2024/06/Blog2-alt.jpg